Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | REAL | TPR |
|---|---|---|
| Price | $9.40 | $113.42 |
| Change today | ▼ 0.11% | ▼ 2.85% |
| Market cap | $1.14B | $22.62B |
| Return, 3 months | -10.9% | -18.6% |
| Return, year to date | -40.4% | -10.4% |
| Return, 1 year | -10.4% | -1.6% |
| P/E (TTM) | -16.8 | 15.6 |
| P/B | -3.0 | 32.7 |
| P/E percentile vs own 5y | 7th | 63rd |
| Dividend yield | – | 1.41% |
| Revenue growth (YoY, latest qtr) | +16.6% | +8.9% |
| Net profit growth (YoY) | -139.6% | +167.3% |
| Gross margin | 74.5% | 77.8% |
| Operating margin | -0.8% | 23.9% |
| Net margin | -10.8% | 19.1% |
| Return on equity | – | 197.1% |
| Analyst target vs. price | +85.1% | +54.4% |
| Analyst buy share | 71% | 93% |
| RSI (14) | 46 | 38 |
| 30-day volatility | 39.3% | 30.5% |
| Max drawdown, 1 year | -52.0% | -32.7% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
